F stands for fructose and fat (original) (raw)

• News & Views
• Published: 09 October 2013

Metabolic syndrome

Nature volume 502, pages 181–182 (2013)Cite this article

• 21k Accesses
• 61 Citations
• 38 Altmetric
• Metrics details

Subjects

Fructose and glucose have the same caloric value, but the two sugars are metabolized differently. It emerges that mice that cannot metabolize fructose are healthier when placed on carbohydrate-rich diets.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

• ATF4-dependent fructolysis fuels growth of glioblastoma multiforme

  • Chao Chen
  • , Zhenxing Zhang
  • … Xinjian Li
    Nature Communications Open Access 16 October 2022

• Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models

  • David S. Ludwig
  • , Caroline M. Apovian
  • … Mark I. Friedman
    European Journal of Clinical Nutrition Open Access 28 July 2022

• Cancer, metabolism, fructose, artificial sweeteners, and going cold turkey on sugar

  • Lewis C Cantley
    BMC Biology Open Access 31 January 2014

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Figure 1: Sugar metabolism.

References

1. Lustig, R. H. J. Am. Diet. Assoc. 110, 1307–1321 (2010).
   Article CAS Google Scholar
2. Feinman, R. D. & Fine, E. J. Nutr. Metab. 10, 45 (2013).
   Article CAS Google Scholar
3. Ishimoto, T. et al. Hepatology http://dx.doi.org/10.1002/hep.26594 (2013).
4. Lanaspa, M. A. et al. Nature Commun. 4, 2434 (2013).
   Article ADS Google Scholar
5. Ventura, E. E., Davis, J. N. & Goran, M. I. Obesity 19, 868–874 (2011).
   Article CAS Google Scholar
6. Stanhope, K. L. et al. J. Clin. Invest. 119, 1322–1334 (2009).
   Article CAS Google Scholar
7. Khandekar, M. J., Cohen, P. & Spiegelman, B. M. Nature Rev. Cancer 11, 886–895 (2011).
   Article CAS Google Scholar
8. Dhingra, R. et al. Circulation 116, 480–488 (2007).
   Article Google Scholar
9. Teff, K. L. et al. J. Clin. Endocrinol. Metab. 94, 1562–1569 (2009).
   Article CAS Google Scholar
10. Jürgens, H. et al. Obes. Res. 13, 1146–1156 (2005).
    Article Google Scholar

Download references

Author information

Authors and Affiliations

1. Costas A. Lyssiotis and Lewis C. Cantley are in the Department of Medicine, Weill Cornell Medical College, New York, New York 10065, USA.,
   Costas A. Lyssiotis & Lewis C. Cantley

Authors

1. Costas A. Lyssiotis
2. Lewis C. Cantley

Corresponding authors

Correspondence toCostas A. Lyssiotis or Lewis C. Cantley.

Ethics declarations

Competing interests

L.C.C. owns equity in, receives compensation from, and serves on the Board of Directors and Scientific Advisory Board of Agios Pharmaceuticals. Agios Pharmaceuticals is identifying metabolic pathways of cancer cells and developing drugs to inhibit such enzymes in order to disrupt tumour-cell growth and survival.

Rights and permissions

About this article

Cite this article

Lyssiotis, C., Cantley, L. F stands for fructose and fat.Nature 502, 181–182 (2013). https://doi.org/10.1038/502181a

Download citation

• Published: 09 October 2013
• Issue date: 10 October 2013
• DOI: https://doi.org/10.1038/502181a

This article is cited by